|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.370 USD | 0.00% |
|
-10.46% | -17.96% |
| Capitalization | 342M 290M 266M 251M 468M 32.26B 472M 3.15B 1.23B 15.49B 1.28B 1.25B 53.49B | P/E ratio 2026 * |
-21.9x | P/E ratio 2027 * | -16.6x |
|---|---|---|---|---|---|
| Enterprise value | 342M 290M 266M 251M 468M 32.26B 472M 3.15B 1.23B 15.49B 1.28B 1.25B 53.49B | EV / Sales 2026 * |
16.7x | EV / Sales 2027 * | 16.7x |
| Free-Float |
95.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 week | -10.46% | ||
| Current month | -9.27% | ||
| 1 month | -8.05% | ||
| 3 months | -17.96% | ||
| 6 months | -22.16% | ||
| Current year | -17.96% |
| 1 week | 1.35 |  | 1.52 |
| 1 month | 1.35 | | 1.75 |
| Current year | 1.35 | | 1.98 |
| 1 year | 0.45 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 3 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 2018-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 2022-11-13 |
| Chief Operating Officer | - | 2010-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 2009-06-30 |
Deborah Andrews
BRD | Director/Board Member | 68 | 2014-04-10 |
Michael Mulroy
CHM | Chairman | 60 | 2024-04-26 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -10.46% | +211.36% | -6.80% | 342M | |
| -0.66% | +0.79% | -17.41% | -14.33% | 43.39B | |
| -1.54% | +6.21% | +34.54% | +27.04% | 34.7B | |
| -0.49% | +1.67% | +250.84% | +462.96% | 30.15B | |
| +0.04% | +13.27% | +19.95% | -3.92% | 29.83B | |
| -2.02% | -1.05% | +30.59% | +26.11% | 28.46B | |
| -3.04% | +8.03% | - | - | 14.74B | |
| -6.96% | +0.55% | +203.99% | +4,495.82% | 14.48B | |
| -0.41% | +0.57% | +134.69% | +112.07% | 12.51B | |
| -0.64% | +0.54% | +5.32% | -4.75% | 12.29B | |
| Average | -1.57% | +2.01% | +97.10% | +566.02% | 22.09B | |
| Weighted average by Cap. | -1.41% | +3.63% | +69.12% | +394.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.5M 17.42M 15.94M 15.04M 28.06M 1.94B 28.31M 189M 73.71M 930M 76.91M 75.29M 3.21B | 20.39M 17.32M 15.85M 14.96M 27.91M 1.93B 28.16M 188M 73.31M 925M 76.5M 74.89M 3.19B |
| Net income | -21.93M -18.63M -17.05M -16.09M -30.02M -2.07B -30.29M -202M -78.85M -995M -82.28M -80.55M -3.43B | -23.09M -19.62M -17.96M -16.95M -31.61M -2.18B -31.89M -213M -83.03M -1.05B -86.64M -84.82M -3.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-08 | 1.370 $ | 0.00% | 1,166,522 |
| 26-05-07 | 1.370 $ | -4.20% | 1,507,184 |
| 26-05-06 | 1.430 $ | -2.05% | 805,832 |
| 26-05-05 | 1.460 $ | +2.82% | 1,175,322 |
| 26-05-04 | 1.420 $ | -7.19% | 2,768,744 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
